Senior Advisor/COO, Bio-Medicines Business Unit, Eli Lilly and Company, United States
Mark Kryah is COO/Senior Advisor in Eli Lilly’s Bio-Medicines Business Unit, leading Phase 3 development in Immunology. He has been leading global development projects for 20+ years, with extensive international and partnership experience. Mark has been involved with DIA for over...
Read More →SK
Senior Director, Data Science and Artificial Intelligence, AstraZeneca, United States
Dr. Shameer Khader is currently working as a Senior Director of Data Science and Artificial Intelligence at AstraZeneca, USA. He leads a global team that focuses on leveraging trans-disciplinary (biomedical, healthcare, and clinical) big data and machine intelligence to accelerate...
Read More →